Company intelligence / Profile preview

eXmoor Pharma

Bristol, England/Somerset/Bristol area, United Kingdomexmoorpharma.com ↗

Ownership: Private
Employees: ~80
Development stage: Commercial

Overview

eXmoor Pharma does not develop its own clinical candidates but enables clients’ cell and gene therapy products from early development through GMP manufacturing. The company has received MHRA MIA(IMP) licensure for investigational medicinal product manufacturing, supporting global clinical trials. It recently partnered to advance gene-modified monocyte therapies into the clinic. No proprietary clinical results as it operates as a CDMO.

Therapeutic areas: Oncology
Modalities: Viral vectors (e.g., AAV)Autologous cell therapiesAllogeneic cell therapiesRNA technologies (including mRNA)
Industry: Contract Manufacturing Organization

Partnerships

Kincell Bio – strategic partnership to expand CGT development/manufacturing capabilities between Europe and the USSignadori Bio – advancing gene-modified monocyte cell therapy targeting solid tumors

Beyond the preview

Go deeper on eXmoor Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on eXmoor Pharma.

Explore the full profile